Mental health status among COVID-19 patients survivors of critical illness in Saudi Arabia: A 6-month follow-up questionnaire study

Table 1 Participant characteristics

Characteristics	n = 48
Age (years), mean ± SD	56.3 ± 17.2
Gender (male), n (%)	30 (62.5)
Weight (kg), mean ± SD	79.4 ± 20.4
APACHE II score, mean ± SD	12.4 ± 8.1
ICU LOS, (days) mean ± SD	9.1 ± 7.4
Hospital LOS (days), mean ± SD	23.1 ± 17.7
Glasgow coma score, mean ± SD	13.8 ± 3.3
Comorbidities, n (%)
Endocrine diseases	24 (50)
Cardiovascular diseases	21 (43.8)
Respiratory diseases	5 (10.4)
Autoimmune/Inflammatory diseases	3 (6.3)
Hematological diseases	3 (6.3)
Renal diseases	3 (6.3)
Neurological diseases	2 (4.2)
Preexisting mental health problems	2 (4.2)
Hepatic diseases	1 (2.1)
ICU course n (%)
Oxygen support	23 (47.9)
Non-invasive mechanical ventilation	6 (12.5)
Mechanical ventilation	5 (10.4)
Corticosteroid	27 (56.3)
Vasopressor	7 (14.7)
Neuromuscular blocking agents	2 (4)
Tocilizumab	8 (16.3)

APACHE II: Acute physiology and chronic health evaluation; ICU: Intensive care unit.